blue background with colorful dots surrounding lungs

IASLC 2021 Hot Topic Meeting: Small Cell Lung Cancer October 29-30, 2021

Registration is now open for the IASLC 2021 Hot Topic Meeting: Small Cell Lung Cancer (SCLC 2021). Register on or before October 1, 2021 for early bird savings.
Journal of Thoracic Oncology

The Journal of Thoracic Oncology 2020 Impact Factor has risen to 15.609

The journal ranks #4 of 64 respiratory system journals and #13 of 242 oncology journals.
Globe on Blue Background with abstract mountains

IASLC 2021 World Conference on Lung Cancer September 8-14, 2021

Register now for the largest international gathering of clinicians, researchers, and scientists in the field of lung cancer and thoracic oncology.
IASLC 2021 Hot Topic Meeting: Small Cell Lung Cancer October 29-30, 2021
The Journal of Thoracic Oncology 2020 Impact Factor has risen to 15.609
IASLC 2021 World Conference on Lung Cancer September 8-14, 2021

Homepage

The International Association for the Study of Lung Cancer

The IASLC is a global multidisciplinary organization dedicated to eradication of all forms of lung cancer. From provision of educational events around the world and virtually to research projects and publications that advance the science of lung cancer, the IASLC's members—consisting of medical, surgical, and radiation oncologists, as well as other thoracic oncology specialists such as nurses, basic scientists, pathologists, radiologists, pulmonologists, statisticians, patient research advocates, patients, and their caregivers—are raising the bar for care of patients with lung cancer.

Explore More

IASLC Seeks Qualified Candidates for CEO Position

The IASLC is currently accepting qualified physicians for the position of Chief Executive Officer. The CEO leads efforts to fulfill the mission, goals, and strategic plan of the IASLC represents the organization internally and externally, and ensures effective operational performance and staff leadership. members with an MD, PhD, or other medical degree and who specialize in thoracic oncology are welcome to apply. 

Due to legal considerations, candidates are required to have U.S. citizenship, U.S. dual citizenship, or permanent residency.

 

In Focus

Language Guide page 1

IASLC Language Guide

In line with the IASLC Equity Statement and in step with the ASCO Language of Respect, we are proud to announce the release of the IASLC Language Guide. The guide was established to instill best practices with commonly used phrases related to patient care. The IASLC will be folding the language found in the guide into all aspects of thoracic oncology education, from abstracts to faculty guidelines to podium presentations. 

Our Impact

8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.

Our Impact

8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.

See More

Our Work

The IASLC Staging Project

The IASLC Staging Project is a global effort to study and improve the current staging system for lung cancer, mesothelioma, thymic and esophageal cancer.

Lung Ambition Alliance

The IASLC has formed an alliance with three other founding organizations to allow scientists, specialists, advocates, and patients to break the barriers limiting progress and double 5-year survival rates of lung cancer by 2025.

In Numbers

8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.
45
Years Experience
15K
Number of Research Awards Funded
15.609
JTO Impact Factor
8K+
Members

Upcoming Meetings & Webinars

IASLC Meeting
Oct 29 - Oct 30 2021
IASLC Meeting
Dec 03 - Dec 04 2021
JTO-CRR_Hero-0820 - Cropped.jpg

Journal of Thoracic Oncology & JTO Clinical and Research Reports

Lung and thoracic specialists count on the IASLC’s journals to provide perspective on innovation in prevention, detention, diagnosis and cutting-edge treatments. As a leading medical journal, JTO focuses on lung and thoracic cancers and is dedicated to presenting original research reviews and opinions from a wide range of disciplines within the medical community. JTO CRR, the official open access journal of the IASLC, complements the JTO by offering authors a gold open access publication option.